Get the Stockscreener App
1.63
20.74%
0.28
Century Therapeutics Inc Stock (IPSC) Latest News
Benitec Biopharma to Participate in Upcoming Investor Conferences in December - The Manila Times
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Century Therapeutics Expands Clinical Focus and Reports Steady Financials for Q3 2024 - MSN
Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - The Malaysian Reserve
Endo, Inc. Partners with MC2 Therapeutics to Bring Wynzora® Cream to Canadian Market - MyChesCo
Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace
Syncona Portfolio Ltd's Strategic Acquisition of Autolus Therape - GuruFocus.com
FMR LLC's Strategic Reduction in Century Therapeutics Inc Holdin - GuruFocus.com
NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve
Carisma Therapeutics and Moderna Unveil Promising Pre-Clinical Data for Anti-GPC3 CAR-M Therapy - MyChesCo
Century Therapeutics to Present Cutting-Edge Preclinical Data at 2024 ASH Annual Meeting - MSN
Ocugen Advances Gene Therapy and Financial Strategies in Q3 2024 - MyChesCo
William Blair Has Positive Estimate for IPSC FY2024 Earnings - Defense World
Palvella Therapeutics Begins Phase 3 Trial for Microcystic Lymphatic Malformations Treatment - MyChesCo
Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates - MSN
FY2024 Earnings Estimate for IPSC Issued By HC Wainwright - Defense World
Context Therapeutics Announces Q3 2024 Financial Results and Strategic Advances - MyChesCo
What Makes Century Therapeutics (IPSC) a New Buy Stock - Yahoo Finance
What is HC Wainwright's Forecast for IPSC FY2024 Earnings? - MarketBeat
William Blair Has Strong Estimate for IPSC FY2024 Earnings - MarketBeat
Cabaletta Bio to Spotlight Groundbreaking Cell Therapies at Guggenheim's Healthcare Innovation Conference! - MyChesCo
Aclaris Therapeutics Highlights Key Advances and Financial Results for Q3 2024 - MyChesCo
Passage Bio CEO Will Chou to Share Insights at Guggenheim Healthcare Innovation Conference! - MyChesCo
Chardan Capital Has Lowered Expectations for Century Therapeutics (NASDAQ:IPSC) Stock Price - MarketBeat
Century Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults - TipRanks
Join Century Therapeutics at Guggenheim’s Healthcare Innovation Conference! - MyChesCo
Century Therapeutics shares target cut, retains Buy rating on updated data - Investing.com UK
HC Wainwright Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $5.00 - MarketBeat
Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Century Therapeutics COO sells $1,267 in stock - Investing.com
Century Therapeutics Reports Q3 Results & Strategic Updates - TipRanks
Century Therapeutics COO sells $1,267 in stock By Investing.com - Investing.com UK
Century Therapeutics earnings beat by $0.08, revenue topped estimates - Investing.com UK
InventHelp Inventor Develops Protective Accessory for Underwear (ASP-336) - Yahoo Finance
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition - The Manila Times
Ichnos Glenmark Innovation (IGI) Announces First Presentation of Data from Phase 1 Study of the Trispecific ISB 2001 in Relapsed/Refractory Multiple Myeloma (r/rMM) at Upcoming ASH Annual Meeting - The Manila Times
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of - The Bakersfield Californian
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting - Yahoo Finance
Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 - Yahoo Finance
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - The Manila Times
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference - GlobeNewswire
Larimar Therapeutics Reports Third-Quarter 2024 Financial and Operational Progress - MyChesCo
We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate - Yahoo Finance
Context Therapeutics to Engage Investors at November Conferences - MyChesCo
electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar? - Yahoo Finance
Context Therapeutics to Showcase Promising Cancer Therapy at SITC Annual Meeting - MyChesCo
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 6.4% in September - MarketBeat
As the Cell Therapy Market Eyes $48 Billion, Bayer Invests $215 Million in Century Therapeutics As Revealed... - WhaTech
Dimensional Fund Advisors LP Acquires New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Artiva, Century, others extend natural-killer autoimmune push - BioWorld Online
Ubiquiti Inc. (NYSE:UI) Shares Sold by Dimensional Fund Advisors LP - Defense World
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):